Science

Jun 23, 2025, 15:18

Myeloma Paper of the Day, June 23rd, suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Patients with extramedullary myeloma (EMM) dx or with solitary plasmacytoma progression have median OS 7.5 years; worse prognosis if with primary or secondary PCL and secondary EMM, high R-ISS, chromosome abnormalities, high LDH.”

Title: Comprehensive evaluation of disease characteristics and outcomes of patients with extramedullary multiple myeloma in the modern era

Authors: Megan Broughton, Subodh Bhatta, Doshi Sonali, Naresh Bumma, Abdullah M. Khan, Srinivas Devarakonda, Elvira Umyarova, Don Benson, Ashley Rosko, Francesca Cottini

You can read the Full Article in Haematologica.

More posts featuring Robert Orlowski.

Abdullah M. Khan Ashley Rosko cancer Don Benson Doshi Sonali Elvira Umyarova Francesca Cottini Megan Broughton multiple myeloma Myeloma Myeloma Paper of the Day Naresh Bumma OncoDaily Oncology Robert Orlowski Srinivas Devarakonda Subodh Bhatta

Neil Ranasinghe: What’s the Difference Between a Clinician and a Technical Writer?

LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery - Amgen

Top 10 Immunotherapy Trials in Lung Cancer to Watch at ESMO 2025

FDA has Granted Full Market Approval for Papzimeos - NIH

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...